Founded 2018
Founders Amit Kumar, CEO, BIOPSIN Sheetal Sinha, CTO, BIOPSIN

Industries are using a century old method to detect pathogens. This takes 5-10 days to get the results. This delay in microbial detection leads to batch spoilage, product recalls, disease outbreaks and loss of human lives. The global economic burden of microbial contamination is well over a hundred billion dollars.

BIOPSIN empower industries to detect pathogens almost in real-time with gold-standard limit of detection. Their device can detect multiple pathogens in a single test, is cost-effective and user-friendly. BIOPSIN are fundamentally changing the way microbial detection is performed today.


Founders

Amit
Kumar

CEO, BIOPSIN

PhD in Chemical & Biomolecular Engineering

Sheetal
Sinha

CTO, BIOPSIN

PhD in Biophysics, expert in microbial interactions & detection

Related

47 Labs

47 Labs

Lighting up the brain for healthcare.
A&B Smart Materials

A&B Smart Materials

Revolutionising cooling technology through the development of novel, smart hydrogels.
AarogyaAI

AarogyaAI

AarogyaAI is an AI-enabled SaaS that diagnoses drug-resistant turberculosis (DR-TB) in hours instead of weeks.
Accelerated Dynamics

Accelerated Dynamics

Technology to drive the 4th industrial revolution.
AccuRx

AccuRx

Powering communications in the healthcare sector.
Ackcio

Ackcio

Extremely reliable, wireless monitoring solutions for the world's most challenging industries.